News Sentiment

HSIC sentiment intelligence

Henry Schein Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Distribution Read-through group
Latest close 84.40 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

-2.3% over one week, +3.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Henry Schein stock stays anchored by 2025 sales and margin trends

Market Reaction

Balanced read

68/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -2.3% Price reacting lower
Trend fit Trend active 3.9% over four weeks
Fair value 16.3% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 26
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
simplywall.st 6
Stock Titan 5
Ad Hoc News 3
Moomoo 3
Ad-hoc-news.de 2
MarketWatch 2
AD HOC NEWS 2

Event Lens

What the news is about

Classified themes
Market update 27
Earnings 11
Macro sensitivity 3
Analyst action 3
Deals and strategy 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
Ad Hoc News Direct company coverage

Henry Schein stock stays anchored by 2025 sales and margin trends

Henry Schein's stock performance is currently framed by its 2025 financial figures, including $12.7 billion in sales (a 2.3% reported decline, but a 2.6% increase in constant currency), $774 million in operating income, and diluted EPS of $2.94. These metrics provide a clear base

Tone
Neutral 50/100
Event
Earnings
Published
17 Jul 2026 03:24
Source
Ad Hoc News
Investing.com South Africa Direct company coverage

Henry Schein stock hits 52-week high at 89.34 USD By Investing.com

Henry Schein Inc. (HSIC) stock reached a new 52-week high of $89.34, reflecting a 25.74% total return over the past year. This milestone follows strong first-quarter 2026 earnings, a strategic partnership with GoTu Technology to enhance dental staffing, and positive analyst upgra

Tone
Positive 74/100
Event
Earnings
Published
16 Jul 2026 19:37
Source
Investing.com South Africa
Ad Hoc News Direct company coverage

Henry Schein stock reflects steady healthcare distribution business

Henry Schein stock provides investors exposure to a global distributor of dental and medical supplies and technology solutions. The company's business model is characterized by recurring demand for consumables driven by ongoing patient care and a mixed revenue stream from both co

Tone
Positive 74/100
Event
Earnings
Published
16 Jul 2026 05:39
Source
Ad Hoc News
Ad-hoc-news.de Direct company coverage

Henry Schein stock holds steady as dental and medical distribution remains a core healthcare backbon

Henry Schein stock remains stable due to its essential role in dental and medical distribution, serving a broad base of healthcare professionals with recurring supplies and equipment. The company's business model is strengthened by integrating technology solutions like practice m

Tone
Positive 74/100
Event
Market update
Published
15 Jul 2026 02:05
Source
Ad-hoc-news.de
MarketWatch Direct company coverage

Henry Schein Inc. stock outperforms competitors on strong trading day

Henry Schein Inc. (HSIC) stock increased by 1.31% to $86.91 on Tuesday, outperforming the S&P 500 Index and the Dow Jones Industrial Average on a strong trading day. This marks the fourth consecutive day of gains for the company's stock. The positive performance occurred as the S

Tone
Positive 75/100
Event
Market update
Published
14 Jul 2026 21:16
Source
MarketWatch
Ad Hoc News Direct company coverage

Henry Schein stock reflects steady health-care distribution business

Henry Schein stock offers investors exposure to a global distributor of dental and medical supplies, catering primarily to independent practitioners and small to mid-sized healthcare organizations. The company's diversified business model, encompassing dental, medical, and techno

Tone
Positive 75/100
Event
Market update
Published
14 Jul 2026 10:50
Source
Ad Hoc News
TradingView Direct company coverage

Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry

The medical supply industry is experiencing strong tailwinds in the second half of 2026, driven by resilient healthcare utilization, rising specialty care demand, and the adoption of digital technologies. Companies like McKesson, Cardinal Health, West Pharmaceutical Services, Ali

Tone
Positive 64/100
Event
Macro sensitivity
Published
14 Jul 2026 07:39
Source
TradingView
The Medical University of South Carolina Direct company coverage

Multi-year Support for Henry Schein Innovation Laboratory

The Medical University of South Carolina (MUSC) announced a multi-year in-kind contribution from Henry Schein, Inc., to advance the Henry Schein Innovation Laboratory at the MUSC James B. Edwards College of Dental Medicine. This investment will support the expansion of digital de

Tone
Positive 71/100
Event
Market update
Published
13 Jul 2026 13:08
Source
The Medical University of South Carolina
Moomoo Direct company coverage

Is Now The Time To Look At Buying Henry Schein, Inc. (NASDAQ:HSIC)?

This article asks if Henry Schein, Inc. (NASDAQ:HSIC) is a good investment opportunity currently. It signals an analysis of whether the present time represents a favorable entry point for potential buyers of the stock.

Tone
Neutral 50/100
Event
Market update
Published
12 Jul 2026 08:38
Source
Moomoo
Moomoo Direct company coverage

BMO Capital Maintains Henry Schein(HSIC.US) With Hold Rating, Raises Target Price to $85

BMO Capital has reiterated its "Hold" rating on Henry Schein (HSIC.US) and increased its target price for the stock to $85.00. This adjustment follows the company's Q1 2026 earnings report, where although earnings per share slightly missed estimates, revenue exceeded expectations

Tone
Neutral 50/100
Event
Earnings
Published
11 Jul 2026 08:08
Source
Moomoo
Ad-hoc-news.de Direct company coverage

Henry Schein stock stays supported by steady dental demand

Henry Schein stock performance is closely linked to its role as a major distributor of dental and medical supplies. The company benefits from consistent demand for dental and medical services, strong margin discipline, and growth through technological solutions. Henry Schein's bu

Tone
Positive 72/100
Event
Earnings
Published
09 Jul 2026 12:13
Source
Ad-hoc-news.de
MarketWatch Direct company coverage

Henry Schein Inc. stock underperforms Wednesday when compared to competitors

Shares of Henry Schein Inc. (HSIC) fell by 4.17% on Wednesday, closing at $83.22. This underperformance occurred during a generally difficult trading session, with the S&P 500 Index (SPX) dropping 0.28% and the Dow Jones Industrial Average (DJIA) declining by 1.09%. The stock's d

Tone
Negative 30/100
Event
Market update
Published
08 Jul 2026 23:38
Source
MarketWatch
GuruFocus Direct company coverage

Henry Schein (HSIC) Coverage Initiated by BMO Capital with Marke

BMO Capital has initiated coverage on Henry Schein Inc (HSIC) with a Market Perform rating and an $85 price target, citing investor uncertainty following a recent CEO change. The firm emphasizes that the company's value creation strategy will largely depend on its operational per

Tone
Neutral 50/100
Event
Analyst action
Published
08 Jul 2026 22:45
Source
GuruFocus
AD HOC NEWS Direct company coverage

Henry Schein focuses on dental and medical distribution as investors watch sector trends

Henry Schein is a major distributor of dental and medical supplies, with its stock attracting investor interest due to its focus on healthcare supply and distribution in the U.S. The company provides a wide range of products, from consumables to advanced equipment, and also offer

Tone
Positive 70/100
Event
Macro sensitivity
Published
08 Jul 2026 10:28
Source
AD HOC NEWS
Sahm Direct company coverage

Henry Schein (HSIC) Could Be 2% Undervalued Following GoTu Partnership

Henry Schein (HSIC) recently partnered with GoTu Technology and was removed from the Russell 1000 Dynamic Index, leading to improved share price momentum. While the company is considered "1.6% Undervalued" with a fair value of $88.07, its current P/E ratio of 25x appears expensiv

Tone
Positive 66/100
Event
Deals and strategy
Published
07 Jul 2026 23:07
Source
Sahm
AD HOC NEWS Direct company coverage

Henry Schein Inc focuses on dental and medical supply distribution as investors watch long term fund

Henry Schein Inc is recognized as a global leader in dental and medical product distribution, with investors closely monitoring its established business model and long-term financial health. The company serves office-based healthcare practitioners by providing a wide array of pro

Tone
Positive 70/100
Event
Macro sensitivity
Published
07 Jul 2026 14:48
Source
AD HOC NEWS
Market source Direct company coverage

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Henry Schein (HSIC) stock appears undervalued, holding a Zacks Rank #2 (Buy) and a Value grade of A. The company's valuation metrics, including its P/E, P/B, P/S, and P/CF ratios, are all favorable when compared to its industry averages, suggesting potential for profit. Given its

Tone
Positive 72/100
Event
Earnings
Published
07 Jul 2026 14:08
Source
Market source
Moomoo Direct company coverage

Evercore ISI Adjusts Price Target on Henry Schein to $100 From $90

Evercore ISI has increased its price target for Henry Schein (NASDAQ: HSIC) to $100 from $90. The analyst firm maintains an Outperform rating on the stock. This adjustment reflects Evercore ISI's updated outlook for the company.

Tone
Positive 73/100
Event
Analyst action
Published
07 Jul 2026 13:08
Source
Moomoo